Drug-Resistant Tuberculosis Treatment Recommendation, and Multi-Class Tuberculosis Detection and Classification Using Ensemble Deep Learning-Based System

Author:

Prasitpuriprecha Chutinun,Jantama Sirima Suvarnakuta,Preeprem ThanawadeeORCID,Pitakaso RapeepanORCID,Srichok ThanatkijORCID,Khonjun SurajetORCID,Weerayuth Nantawatana,Gonwirat Sarayut,Enkvetchakul Prem,Kaewta ChutchaiORCID,Nanthasamroeng NatthapongORCID

Abstract

This research develops the TB/non-TB detection and drug-resistant categorization diagnosis decision support system (TB-DRC-DSS). The model is capable of detecting both TB-negative and TB-positive samples, as well as classifying drug-resistant strains and also providing treatment recommendations. The model is developed using a deep learning ensemble model with the various CNN architectures. These architectures include EfficientNetB7, mobileNetV2, and Dense-Net121. The models are heterogeneously assembled to create an effective model for TB-DRC-DSS, utilizing effective image segmentation, augmentation, and decision fusion techniques to improve the classification efficacy of the current model. The web program serves as the platform for determining if a patient is positive or negative for tuberculosis and classifying several types of drug resistance. The constructed model is evaluated and compared to current methods described in the literature. The proposed model was assessed using two datasets of chest X-ray (CXR) images collected from the references. This collection of datasets includes the Portal dataset, the Montgomery County dataset, the Shenzhen dataset, and the Kaggle dataset. Seven thousand and eight images exist across all datasets. The dataset was divided into two subsets: the training dataset (80%) and the test dataset (20%). The computational result revealed that the classification accuracy of DS-TB against DR-TB has improved by an average of 43.3% compared to other methods. The categorization between DS-TB and MDR-TB, DS-TB and XDR-TB, and MDR-TB and XDR-TB was more accurate than with other methods by an average of 28.1%, 6.2%, and 9.4%, respectively. The accuracy of the embedded multiclass model in the web application is 92.6% when evaluated with the test dataset, but 92.8% when evaluated with a random subset selected from the aggregate dataset. In conclusion, 31 medical staff members have evaluated and utilized the online application, and the final user preference score for the web application is 9.52 out of a possible 10.

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Reference85 articles.

1. World Health Organization (2020). Global Tuberculosis Report 2020, World Health Organization.

2. Pretomanid Development and Its Clinical Roles in Treating Tuberculosis;Fekadu;J. Glob. Antimicrob. Resist.,2022

3. Childhood Tuberculosis: An Overview;Faddoul;Adv. Pediatr.,2015

4. Farrar, J., Hotez, P.J., Junghanss, T., Kang, G., Lalloo, D., and White, N.J. (2013). Manson’s Tropical Diseases, Saunders Ltd.. [23rd ed.].

5. Screening for Latent Tuberculosis Infection Prior to Biologic Therapy in Patients with Chronic Immune-Mediated Inflammatory Diseases (IMID): Interferon-Gamma Release Assay (IGRA) versus Tuberculin Skin Test (TST);Sellami;Egypt. Rheumatol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3